Impact of BTK Inhibition on Monocytic Myeloid-Derived Suppressor Cells in CLL
October 8th 2019Arantxa Romero-Toledo, PhD student, at the Centre for Haemato-Oncology, Barts Cancer Institute, discusses the impact of BTK inhibition on monocytic myeloid-derived suppressor cells (MDSCs) in chronic lymphocytic leukemia (CLL).
Read More